Asker Healthcare Group revenue and financials
kr 66.30Change from previous close: −0.60%Absolute change: −kr 0.40
In the fiscal year ended December 2025, Asker Healthcare Group reported revenue of kr 16.79B (+11.73% year over year). Net income was kr 492M, a net margin of 2.9%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +11.73%
- 2025 vs 2024
- Net income growth
- +36.67%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 2.4%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | 1,328 | 1,227 | 1,052 | 976 |
| Depreciation and amortization | 816 | 608 | 548 | 395 |
| Capital expenditure | -590 | -348 | -151 | -123 |
| Investing cash flow | -2,906 | -1,457 | -783 | -1,860 |
| Financing cash flow | 2,025 | 305 | -83.0 | 572 |
| Debt issued | 5,098 | 467 | 77.0 | 902 |
| Debt repaid | -4,258 | -49.0 | -41.0 | -582 |
| Effect of exchange rates | -53.0 | 24.0 | -5.0 | 29.0 |
| Net change in cash | 447 | 75.0 | 186 | -312 |
| Free cash flow | 738 | 879 | 901 | 853 |